Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889544) titled 'Prospective Comparison of Pro-Adrenomedullin, C-Reactive Protein, and Neutrophil-to-Lymphocyte Ratio for Diagnosing Acute Appendicitis' on Oct. 16.
Study Type: Observational
Primary Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital
Condition:
Acute Appendicitis
Intervention:
Diagnostic Test: Serum Pro-Adrenomedullin Measurement
Recruitment Status: Recruiting
Date of First Enrollment: August 1, 2026
Target Sample Size: 400
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07889544
Disclaimer: Curated by HT Syndication....